Top Banner
Dr. Aga Syed Sameer Lecturer (Demonstrator) Department of Biochemistry, Medical College, Sher-I-Kashmir Institute of Medical Sciences, Bemina, Srinagar, Kashmir, 190010. India. Nucleic Acid Metabolism Pyrimidine Metabolism
18

Nucleic acid metabolism lecture nam04

Aug 08, 2015

Download

Science

Aga Syed Sameer
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Nucleic acid metabolism lecture nam04

Dr. Aga Syed SameerLecturer (Demonstrator)

Department of Biochemistry,

Medical College,

Sher-I-Kashmir Institute of Medical Sciences,

Bemina, Srinagar, Kashmir, 190010. India.

Nucleic Acid MetabolismPyrimidine Metabolism

Page 2: Nucleic acid metabolism lecture nam04

Pyrimidine Biosynthesis

• UMP (Uridine Monophosphate)• Precursor to

• TMP and CTP

• Utilizes (Substrates)• One Aspartate

• γ-NH3 of Glutamine

• CO2 is recycled (Used in 1st step and released back in last)

• Water molecule

• NAD+

• ATP’s (Two : Till UMP Synthesis)

• Methyl group of THF + GTP {dTMP Synthesis}

• NH3 of Glutamine + ATP (2 Equivalent) {CTP Synthesis}

Page 3: Nucleic acid metabolism lecture nam04

2 ATP + HCO3- + Glutamine + H2O

CO

O PO3-2

NH2

Carbamoyl Phosphate

NH2

C

N

H

CH

CH2

C

COOO

HO

O

Carbamoyl Aspartate

HN

C

N

H

CH

CH2

C

COOO

O

Dihydroorotate

HN

C

N

H

C

CH

C

COOO

O

Orotate

HN

C

N

C

CH

C

COOO

O

HH

CH2

OH OH

H H

OO

2-O3P

Orotidine-5'-monophosphate

(OMP)

HN

C

N

CH

CH

C

O

O

HH

CH2

OH OH

H H

OO

2-O3P

Uridine Monophosphate

(UMP)

2 ADP +

Glutamate +

Pi

Carbamoyl

Phosphate

Synthetase II

Aspartate

Transcarbamoylase

(ATCase)

Aspartate

Pi

H2O

Dihydroorotase

Quinone

Reduced

QuinoneDihydroorotate

Dehydrogenase

PRPP PPi

Orotate Phosphoribosyl

Transferase

CO2

OMP

Decarboxylase

Pyrimidine Biosynthesis

Page 4: Nucleic acid metabolism lecture nam04

Enzymes and Reactions• 2 condensation Rxns: form carbamoyl aspartate and

dihydroorotate (intramolecular)

• Dihydroorotate dehydrogenase (FMN) is an intra-mitochondrial enzyme; oxidizing power comes from ubiquinone reduction

• Attachment of base to ribose ring is catalyzed by OPRT; PRPP provides ribose-5-P.

• OMP Decarboxylase enhances the rate of decarboxylation by a factor of 2x1023

• Channeling: • Enzymes 1, 2, and 3 are on same chain;

• Enzymes 5 and 6 are on same chain

Page 5: Nucleic acid metabolism lecture nam04

CTP and UTP synthesis• UMP is then converted UDP &

UTP

• The conversion takes place by the action of Nucleoside Mono/Di Phosphate Kinases.

• CTP formed from UTP via CTP Synthetase driven by ATP hydrolysis • Glutamine provides amide

nitrogen

Page 6: Nucleic acid metabolism lecture nam04

Conversion of Ribonucleotidesto Deoxyribonucleotides• Ribonucleotide reductase

• NADP

• Thioredoxin reductase

Page 7: Nucleic acid metabolism lecture nam04

Regulation of RNR’s

• ATP activates

• dATP Inhibits

Page 8: Nucleic acid metabolism lecture nam04

dTMP synthesis• dUMP formed; produces dTMP via Thymidylate

Synthetase• N5,N10 Methylene THF provides methyl group

• THF is first reduced and then methylated

Page 9: Nucleic acid metabolism lecture nam04

dTMP synthesis

Page 10: Nucleic acid metabolism lecture nam04

Regulation• Differs between bacteria and animals

• Bacteria – regulation at ATCase rxn

• Animals – regulation at carbamoyl phosphate synthetaseII

• UDP and UTP inhibit enzyme;

• ATP and PRPP activate it

• Also UMP and CMP competitively inhibit OMP Decarboxylase

Page 11: Nucleic acid metabolism lecture nam04

Degradation of Pyrimidines• CMP and UMP degraded to bases similarly to purines

• Dephosphorylation

• Deamination

• Glycosidic bond cleavage

• Uracil reduced in liver, forming β-Alanine

• Is then converted to malonyl-CoA used in fatty acid synthesis for energy metabolism

• dTMP is degraded to β-Amino Isobutyrate

• Is then converted to methyl malonyl-CoA used in fatty acid synthesis for energy metabolism

Page 12: Nucleic acid metabolism lecture nam04

Cancer is a clonal disorder.

It is composed of malignant cells of

several distinguishable characteristics

such as:

immortality,

faster growth,

unable to establish cell-cell

interaction,

propensity to invade, metastasize and

grow in an abnormal cellular

environment.

Hanahan D and Weinberg RA. The hallmarks of cancer. Cell. 2000; 100:57-70.

Cancer

Page 13: Nucleic acid metabolism lecture nam04

Molecules Implicated in Colorectal Cancer PathogenesisIn Kashmiri Population

Aga Syed Sameer

Page 14: Nucleic acid metabolism lecture nam04

Anti-Folate Drugs • Cancer cells consume dTMP quickly for DNA

replication

• Interfere with Thymidylate Synthase rxn to decrease dTMP production • (fluorodeoxyuridylate – irreversible inhibitor) – also affects

rapidly growing normal cells (hair follicles, bone marrow, immune system, intestinal mucosa)

• Dihydrofolate reductase step can be stopped competitively (DHF analogs)

• Anti-Folates: Aminopterin, methotrexate, trimethoprim

Page 15: Nucleic acid metabolism lecture nam04

Thymidylate Synthesis and Cancer Chemotherapy

• Thymidylate synthase is target for fluorouracil• Action is 5-fluorouracil (5-FU)is converted to 5-fluoro-2’-

deoxyuridylate (dUMP structural analog)

• Then 5-fluoro-2’-deoxyuridylate binds to the enzyme Thymidylate Synthase and undergoes a partial reaction where part of the way through 5-fluoro-2’-deoxyuridylate forms a covalent bridge between Thymidylate Synthase and N5, N10-Methylene THF and is an irreversible inhibition.• Normally, the enzyme, Thymidylate Synthase and the vitamin would

NOT be linked together permanently

• This type of inhibition is called “suicide-based enzyme inhibition”

Page 16: Nucleic acid metabolism lecture nam04

Thymidylate Synthesis and Cancer Chemotherapy

Page 17: Nucleic acid metabolism lecture nam04

Methotrexate• Competitive inhibitor of Dihydrofolate Reductase

• Used in,

• Acute lymphoblastic leukemia

• Osteosarcoma in children

• Solid tumor treatment

• Breast, head, neck, ovary, and bladder

• Prevents regeneration of tetrahydrofolate and removes activity of the active forms of folate

Page 18: Nucleic acid metabolism lecture nam04